Allergen immunotherapy in patients with severe asthma: A need for prospective trials
- PMID: 38358039
- PMCID: PMC11216075
- DOI: 10.1002/ppul.26918
Allergen immunotherapy in patients with severe asthma: A need for prospective trials
Keywords: allergy shots; clinical trials.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
References
-
- Noon L. Prophylactic inoculation against hay fever. Historical document. Ann Allergy. 1960;18:287–291. - PubMed
-
- Cox LS, Murphey A, Hankin C. The cost-effectiveness of allergen immunotherapy compared with pharmacotherapy for treatment of allergic rhinitis and asthma. Immunol Allergy Clin North Am. 2020;40(1):69–85. - PubMed
-
- Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy. 2002;57(9):785–790. - PubMed
-
- Ibero M, Castillo MJ. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol. 2006;16(3):194–202. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical